Maruti Suzuki India has made a spectacular comeback in 2022 but the August sales data show signs of continued weakness. CJ believes that investors are getting too excited for nothing while Santo is adamant company is on recovery path. Watch the duo debate what lies ahead for India's largest car maker. Plus their thoughts on BHEL, Aurobindo Pharma and Adani Enterprises.
first published: Sep 2, 2022 08:44 am
A collection of the most-viewed Moneycontrol videos.
Infosys Q2 Earnings Live | Decoding Infosys Q2 Earnings | Earnings Express
Indian stocks Vs Gold, Silver, Global equities: Manish Chokhani on where to sow, where to harvest
Can Nifty Reclaim 25,400 After Strong Comeback; Infosys, Axis, Eternal In Focus|Opening Bell Live
Sensex, Nifty resume rally after 2-day pause, financials shine bright | Closing Bell
